This is a preview of subscription content, log in via an institution to check access.
References
Chen, Z. et al. J. Virol. 87, 9547–9557 (2013).
Hall, A.J. et al. Emerg. Infect. Dis. 19, 1198–1205 (2013).
Payne, D.C. et al. N. Engl. J. Med. 368, 1121–1130 (2013).
Hall, A.J., Curns, A.T., McDonald, L.C., Parashar, U.D. & Lopman, B.A. Clin. Infect. Dis. 55, 216–223 (2012).
Bartsch, S.M., Lopman, B.A., Hall, A.J., Parashar, U.D. & Lee, B.Y. Vaccine 30, 7097–7104 (2012).
Simmons, K., Gambhir, M., Leon, J. & Lopman, B. Emerg. Infect. Dis. 19, 1260–1267 (2013).
Atmar, R.L. et al. N. Engl. J. Med. 365, 2178–2187 (2011).
Tamminen, K., Lappalainen, S., Huhti, L., Vesikari, T. & Blazevic, V. PLoS One 8, e70409 (2013).
Fang, H., Tan, M., Xia, M., Wang, L. & Jiang, X. PLoS ONE 8, e63269 (2013).
Rights and permissions
About this article
Cite this article
Willyard, C. First vaccines targeting 'cruise ship virus' sail into clinical trials. Nat Med 19, 1076–1077 (2013). https://doi.org/10.1038/nm0913-1076
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0913-1076
- Springer Nature America, Inc.